Dimethylone, or βk-MDDMA, belongs to the substituted cathinone class and possesses stimulant and empathogenic properties. Unlike its amphetamine counterpart, MDDM, which is believed to have little to no activity, dimethylone has demonstrated its ability to substitute for methamphetamine and MDMA in animal studies. Consequently, it has been marketed and sold as a designer drug.
|CAS Number||765231-58-1 |
|Chemical and physical data|
|Molar mass||221.256 g·mol−1|
1. What is Dimethylone?
Dimethylone, or βk-MDDMA, is a synthetic substance in the substituted cathinone class. It is recognized for its stimulant and empathogenic effects.
2. How does Dimethylone work?
Dimethylone acts as a stimulant and empathogen by affecting neurotransmitter activity in the brain. It primarily influences the release and reuptake of certain neurotransmitters, resulting in heightened energy and empathic feelings.
3. What are the effects of Dimethylone?
The effects of Dimethylone can include increased alertness, elevated mood, and enhanced empathy. Users may also experience increased sociability and sensory perception. However, individual responses may vary.
4. Is Dimethylone legal?
The legal status of Dimethylone varies by country and jurisdiction. In many places, it falls under controlled substance regulations, making its possession, sale, or use illegal without proper authorization.
5. Are there health risks associated with Dimethylone use?
The long-term health risks of Dimethylone are not well understood due to limited research. However, as a stimulant, it may lead to increased heart rate, elevated blood pressure, and the potential for addiction or psychological dependence.
6. Is Dimethylone addictive?
Like many stimulant drugs, Dimethylone has the potential for psychological dependence or addiction. Regular and excessive use can lead to cravings and withdrawal symptoms.
7. How is Dimethylone typically consumed?
Dimethylone is often ingested orally, commonly as a pill or capsule. Some individuals may also insufflate (snort) it, although this method can be harsh on the nasal passages.
- Anvisa (2023-07-24): This document, published in Brazilian Portuguese, represents Collegiate Board Resolution No. 804. It pertains to the lists of substances under special control, encompassing narcotics, psychotropics, precursors, and other regulated substances. It was officially published in the Diário Oficial da União on July 25, 2023, and provides essential regulatory information.
- Zaitsu K, Katagi M, Kamata HT, Miki A, Tsuchihashi H (2008): This research explores the discrimination and identification of regioisomeric β-keto analogues of 3,4-methylenedioxyamphetamines using gas chromatography-mass spectrometry. It contributes to the field of forensic toxicology and substance analysis.
- Kikura-Hanajiri R, Uchiyama N, Goda Y (May 2011): This study, published in Legal Medicine, surveys current trends in the abuse of psychotropic substances and plants in Japan. It provides insights into substance abuse patterns and their implications.
- Krotulski AJ, Mohr AL, Fogarty MF, Logan BK (October 2018): This research delves into the detection of novel stimulants in oral fluid from individuals who reported ingestion of substances like ecstasy, Molly, and MDMA. It sheds light on the presence of these substances in biological samples.
- Gatch MB, Dolan SB, Forster MJ (June 2019): This study investigates locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats. It contributes to our understanding of the behavioral effects of these substances.
- “Orange Book – Controlled Substances”: This resource, provided by the U.S. Drug Enforcement Administration, offers information about controlled substances, their classifications, and regulatory aspects. It serves as a reference for substances under regulatory control in the United States.